News

CIDRAP2h
Study: mRNA COVID vaccines cost-effective for US seniors, and under some scenarios, younger adults
Vaccination was cost saving for participants aged 65 years and older. In phase 2 analyses, an additional dose was ...
Are mRNA Vaccines Safe — and Should You Still Get a COVID Shot? Doctors on the Pros and Cons
Clinical trials have shown the mRNA vaccines for COVID-19 are safe and effective, especially at preventing severe illness, ...
Scientific American3h
Why mRNA Vaccines Are So Revolutionary—And What’s at Stake if We Lose Them
The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...
UPenn, where mRNA vaccine tech was pioneered, will not lose funding as feds cut $500M in mRNA grants
There have been no changes to the licensing and royalty agreements related to mRNA research that have netted the university ...
US rejection of mRNA vaccines shows ‘lack of respect for science,’ says Nobel laureate
The Nobel Prize winning scientist behind mRNA vaccine technology has attacked the US health secretary’s plan to effectively ...
Jerome Adams, ex-Trump surgeon general, says mRNA vaccine cuts are 'going to cost lives'
Jerome Adams, the U.S. Surgeon General under President Trump's first term, is criticizing his administration's cuts to mRNA ...
HHS phases out mRNA vaccine trials for COVID-19, bird flu
HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine ...
McKnight's Long-Term Care News19h
HHS makes mRNA vaccine project cuts as booster fatigue marks changing public attitude toward shots
On Tuesday, the US Department of Health and Human Services disclosed the end of funding for 22 mRNA vaccine projects — a ...